50th ASH Annual Meeting and Exposition (December 6 - 9, 2008): Chronic Lymphocytic Leukemia

Before you can access ASH's online program, you must agree to the following:

Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
For the research and study to be eligible for presentation at the ASH annual meeting, information contained in the abstract, as well as additional data and information to be presented about the research and/or study at the annual meeting, may not be made public before the abstract has been published/presented at the ASH annual meeting.

Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

Chronic Lymphocytic Leukemia

Saturday, December 6, 2008: 9:30 AM-11:00 AM

3007-3009-3011 - West (Moscone Center)

Sunday, December 7, 2008: 7:30 AM-9:00 AM

3007-3009-3011 - West (Moscone Center)

Molecular Profiling and Clinical Impact in CLL

John G. Gribben, MD, DSc

Institute of Cancer, Centre for Medical Oncology, Barts and the London School of Medicine, London, United Kingdom

Disease-Specific Complications of CLL

Claire E. Dearden, MD

The Royal Marsden Hospital, Sutton, Surrey, United Kingdom

Novel Treatments for CLL

Susan O'Brien, MD

Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX

See more of: Education Program

<< Previous Session | Next Session >>